Keywords: دوتاستراید; Hair growth cycle; Hair pigmentation; Gray hair; Hair biology; Minoxidil; Finasteride; Dutasteride; PRP;
مقالات ISI دوتاستراید (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: دوتاستراید; DUT; dutasteride; SD; solid dispersion; DW; distilled water; FE-SEM; field emission scanning electron microscope; DSC; differential scanning calorimetry; PXRD; powder X-ray diffraction; ATR-FT-IR spectroscopy; attenuated total reflectance Fourier transfor
Simultaneous estimation of dutasteride and tamsulosin hydrochloride in tablet dosage form by vierordt's method
Keywords: دوتاستراید; Dutasteride; Tamsulosin HCl; Simultaneous equation method; UV-Visible double beam Spectroscopy and Urimax-D tablets;
Keywords: دوتاستراید; Dementia; 5-Alpha reductase inhibitors; Finasteride; Dutasteride;
Keywords: دوتاستراید; Alopecia; Chitosan conjugation; Dutasteride; Nanostructured lipid carriers; Topical delivery;
Keywords: دوتاستراید; prostatic hyperplasia; dutasteride; finasteride; heart failure; drug-related side effects and adverse reactions; 5ARI; 5α-reductase inhibitor; BPH; benign prostatic hyperplasia; DHT; dihydrotestosterone;
Keywords: دوتاستراید; Parkinson's disease; Estrogen; MPTP; 6-OHDA; Dopamine; Striatum; PPT; G1; GPER1; Finasteride; Dutasteride; Neuroprotection
Keywords: دوتاستراید; 5-Alpha-reductase inhibitors; Finasteride; Dutasteride; Combination drug therapy; Prostatic hyperplasia; Lower urinary tract symptoms;
Keywords: دوتاستراید; prostatic neoplasms; prostatic neoplasms; castration-resistant; dutasteride; MDV 3100; antineoplastic combined chemotherapy protocolsADT, androgen deprivation therapy; AR, androgen receptor; BPH, benign prostatic hyperplasia; CI, combination index; CRPC,
5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
Keywords: دوتاستراید; L-DOPA; 5alpha-reductase; Dutasteride; Parkinson's disease; Dyskinesia; 6-OHDA; Neurosteroids; Dopamine;
Estudio transversal acerca de los hábitos de prescripción en alopecia androgénica de los dermatólogos en España en 2017
Keywords: دوتاستراید; Alopecia androgénica; Finasterida; Dutasterida; Láser de baja potencia; Minoxidil; Nutricosméticos; Androgenetic alopecia; Finasteride; Dutasteride; Low-level laser therapy; Minoxidil; Nutricosmetics;
Change of the 5α/5β ratio of urinary steroid metabolites in benign prostatic hyperplasia patients treated with dutasteride
Keywords: دوتاستراید; USP; urinary steroid profiling; GC/MS; gas chromatography/mass spectrometry; BPH; benign prostatic hyperplasia; DHT; dihydrotestosterone; DUT; dutasteride; 5AR; 5α-reductase; 5ARI; 5α-reductase inhibitor; FIN; finasteride; IPSS; International Prostate S
Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition
Keywords: دوتاستراید; 5α-Reductase inhibitors; Active surveillance; Chemoprevention; Dutasteride; Finasteride; NKX3.1; Precision cancer prevention; Prostate cancer;
Novedades terapéuticas en tricologÃa
Keywords: دوتاستراید; TricologÃa; Alopecia androgénica; Dutasterida; Alopecia areata; Ruxolitinib; Alopecia frontal fibrosante; VÃa Wnt; Láser de baja potencia; Hair loss treatments; Androgenetic alopecia; Dutasteride; Alopecia areata; Ruxolitinib; Frontal fibrosing alopec
Randomized non-inferiority trial of Bicalutamide and Dutasteride versus LHRH agonists for prostate volume reduction prior to I-125 permanent implant brachytherapy for prostate cancer
Keywords: دوتاستراید; Prostate; Cytoreduction; Brachytherapy; Dutasteride; Bicalutamide
Improved oral absorption of dutasteride via Soluplus®-based supersaturable self-emulsifying drug delivery system (S-SEDDS)
Keywords: دوتاستراید; Dutasteride; Supersaturable self-emulsifying drug delivery system; Soluplus®; Oral absorption; Bioavailability
The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease
Keywords: دوتاستراید; Finasteride; Dutasteride; MPTP; Neuroprotection; Dopamine; Striatum;
A randomised, double-blind study comparing the addition of bicalutamide with or without dutasteride to GnRH analogue therapy in men with non-metastatic castrate-resistant prostate cancer
Keywords: دوتاستراید; Castration-resistant prostate cancer (CRPC); Dutasteride; Bicalutamide; Prostate-specific antigen (PSA); Androgen deprivation therapy (ADT);
Testosterone Supplementation in Hypogonadal Men on 5âARI Therapy
Keywords: دوتاستراید; Benign Prostatic Hyperplasia; Testosterone; Finasteride; Dutasteride; Hypogonadism;
Alcohol Intake Increases High-grade Prostate Cancer Risk Among Men Taking Dutasteride in the REDUCE Trial
Keywords: دوتاستراید; Prostate cancer; Dutasteride; Alcohol trial;
Surfactant/ionic liquid aqueous two-phase system extraction coupled with spectrofluorimetry for the determination of dutasteride in pharmaceutical formulation and biological samples
Keywords: دوتاستراید; Dutasteride; Surfactant; Ionic liquids; Aqueous two-phase system
Next-generation steroidogenesis inhibitors, dutasteride and abiraterone, attenuate but still do not eliminate androgen biosynthesis in 22RV1 cells in vitro
Keywords: دوتاستراید; DHEA; dehydroepiandrosterone; DHT; dihydrotestosterone; LHRH; luteinizing hormone releasing hormone; LH; luteinizing hormone; AR; androgen receptor; CRPC; castration resistant prostate cancer; PSA; prostate specific antigen; SRD5A1/2; 5-alpha-reductase is
Obesity Is Associated with Increased Prostate Growth and Attenuated Prostate Volume Reduction by Dutasteride
Keywords: دوتاستراید; Prostate; Growth and development; Obesity; Dutasteride; 5α-reductase inhibitors; Prostatic hyperplasia; Ultrasonography
The REDUCE Follow-Up Study: Low Rate of New Prostate Cancer Diagnoses Observed During a 2-Year, Observational, Followup Study of Men Who Participated in the REDUCE Trial
Keywords: دوتاستراید; dutasteride; prostatic neoplasms; diagnosis; biopsy; neoplasm grading5ARI, 5α-reductase inhibitor; PSA, prostate specific antigen; SAE, serious adverse event
Nonsurgical Therapy for Hair Loss
Keywords: دوتاستراید; Androgenetic alopecia; Medical therapy for pattern hair loss; Minoxidil; Finasteride; Dutasteride; Low-level laser therapy for hair loss;
Predictors of Pathological Progression among Men with Localized Prostate Cancer Undergoing Active Surveillance: a Sub-Analysis of the REDEEM Study
Keywords: دوتاستراید; watchful waiting; dutasteride; disease progression; prostate-specific antigen; prostatic neoplasms5-ARI, 5α-reductase inhibitor; AS, active surveillance; DRE, digital rectal examination; I-PSS, International Prostate symptom Score; PSA, prostate specific
MAPPED study design: A 6 month randomised controlled study to evaluate the effect of dutasteride on prostate cancer volume using magnetic resonance imaging
Keywords: دوتاستراید; Randomised controlled trial; Prostate cancer; Magnetic resonance imaging; Dutasteride
Pattern Hair Loss in Men
Keywords: دوتاستراید; Male pattern hair loss; Androgenetic alopecia; Hair loss; Minoxidil; Finasteride; Dutasteride; Prostaglandin analogues;
Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
Keywords: دوتاستراید; Prostate; Finasteride; Dutasteride; Adverse Events; Sexual Dysfunction
Prostate cancer incidence in patients on 5α-reductase inhibitors for lower urinary tract symptoms: A 14-year retrospective study
Keywords: دوتاستراید; 5-ARI, 5α-reductase inhibitors; LUTS, lower urinary tract symptoms; PC, prostate cancer; PCPT, prostate cancer prevention trial; PSA, prostate specific antigen; TRUS, transrectal ultrasoundProstate cancer; Finasteride; Dutasteride; 5α-Reductase inhibitors
Prostate Biopsy in Response to a Change in Nadir Prostate Specific Antigen of 0.4 ng/ml after Treatment with 5α-Reductase Inhibitors Markedly Enhances the Detection Rate of Prostate Cancer
Keywords: دوتاستراید; early detection of cancer; prostatic neoplasms; prostate-specific antigen; finasteride; dutasteride; 5aR; 5α-reductase; 5aRI; 5α-reductase inhibitor; BPH; benign prostatic hyperplasia; CaP; prostate cancer; DRE; digital rectal examination; PSA; prostate
Inhibiteurs des 5 alpha-réductases et cancer de la prostate : une mise au point du Comité de cancérologie de l'Association française d'urologie
Keywords: دوتاستراید; Cancer de la prostate, Chimioprévention; Dunastéride, Finastéride, Inhibiteurs de la 5 alpha-réductase; Prostate cancer; Chemoprevention; Dutasteride; Finasteride; 5 alpha-reductase inhibitors;
Iperplasia prostatica benigna sintomatica: ruolo degli inibitori della 5-alfa-reduttasi nella prevenzione della ritenzione urinaria acuta e degli interventi chirurgici
Keywords: دوتاستراید; Benign prostatic hyperplasia; 5-alpha-reductase inhibitors; Finasteride; Dutasteride;
Dutasteride monotherapy in men with serologic relapse following radical therapy for adenocarcinoma of the prostate: A pilot study
Keywords: دوتاستراید; Dutasteride; Prostatic neoplasms; Clinical trial; Prostate
Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy
Keywords: دوتاستراید; 5‐Alpha Reductase Inhibitors and Sexual Dysfunction; Dutasteride; Erectile Dysfunction; Rat Corpus Cavernosum
Effect of Dutasteride on Prostate Biopsy Rates and the Diagnosis of Prostate Cancer in Men with Lower Urinary Tract Symptoms and Enlarged Prostates in the Combination of Avodart and Tamsulosin Trial
Keywords: دوتاستراید; Benign prostatic hyperplasia; Biopsy; Dutasteride; Prevention and control; Prostate cancer; Risk reduction; Tamsulosin
The Effect of Dutasteride on the Usefulness of Prostate Specific Antigen for the Diagnosis of High Grade and Clinically Relevant Prostate Cancer in Men With a Previous Negative Biopsy: Results From the REDUCE Study
Keywords: دوتاستراید; prostatic neoplasms; dutasteride; prostate-specific antigen; sensitivity and specificity5ARI, 5α-reductase inhibitor; AUC, area under the curve; NPV, negative predictive value; PPV, positive predictive value; PSA, prostate specific antigen; REDUCE, REduct
Dutasteride Reduces Prostatitis Symptoms Compared With Placebo in Men Enrolled in the REDUCE Study
Keywords: دوتاستراید; 5-alpha reductase inhibitors; dutasteride; prostatitis; 5ARI; 5α-reductase inhibitor; BPH; benign prostatic hyperplasia; CP; chronic prostatitis; CPCRN; Chronic Prostatitis Collaborative Research Network; CPPS; chronic pelvic pain syndrome; CPSI; Chronic
Coste-efectividad de la combinación dutasterida y tamsulosina en el tratamiento de la hiperplasia benigna de próstata en España
Keywords: دوتاستراید; Hiperplasia benigna de próstata; combinación; Tamsulosina; Dutasterida; Coste-efectividad; Benign prostatic hyperplasia; Combination therapy; Dutasteride; Tamsulosin; Cost-effectiveness;
Prostate Cancer Detection and Dutasteride: Utility and Limitations of Prostate-Specific Antigen in Men with Previous Negative Biopsies
Keywords: دوتاستراید; Prostate cancer; 5 alpha reductase inhibitor; Dutasteride; PSA; Biopsy; Chemoprevention
The Effects of Chronic 5âAlphaâReductase Inhibitor (Dutasteride) Treatment on Rat Erectile Function
Keywords: دوتاستراید; Dutasteride; Erectile Function; 5âAlpha Reductase Inhibitors; Benign Prostatic Hypertrophy; Dihydrotestosterone; Sexual Dysfunction;
Adverse Side Effects of 5뱉Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
Keywords: دوتاستراید; Finasteride; Dutasteride; Alopecia; Benign Prostatic Hyperplasia; Sexual Dysfunction Depression; Gynecomastia;
Consequences of Switching 5α-Reductase Inhibitors on Prostate Specific Antigen Velocity
Keywords: دوتاستراید; prostate; prostate-specific antigen; finasteride; dutasteride; drugs; generic; 5AR; 5α-reductase; 5ARI; 5AR inhibitor; BPH; benign prostatic hyperplasia; CaP; prostate cancer; DHT; dihydrotestosterone; EDW; Enterprise Data Warehouse; LUTS; lower urinary
The potent synthetic androgens, dimethandrolone (7α,11β-dimethyl-19-nortestosterone) and 11β-methyl-19-nortestosterone, do not require 5α-reduction to exert their maximal androgenic effects
Keywords: دوتاستراید; Synthetic androgens; Hormonal therapy for men; 5α-Reductase; Dutasteride; Accessory sex glands; Androgen receptor
Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study
Keywords: دوتاستراید; androgenetic alopecia; dutasteride; male pattern hair loss; treatment5AR, 5 alpha reductase; DHT, dihydrotestosterone; HGI, hair growth index; MPHL, male pattern hair loss
The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study
Keywords: دوتاستراید; Benign prostatic hyperplasia; Combination drug therapy; Dutasteride; Lower urinary tract symptoms; Prostate; Surgery; Tamsulosin; Urinary retention
Enzyme-linked immunosorbent assays for doping control of 5α-reductase inhibitors finasteride and dutasteride
Keywords: دوتاستراید; Finasteride; Dutasteride; 5α-Reductase inhibitors; Doping control; Enzyme-linked immunosorbent assay
Chemoprevention of Prostate Cancer
Keywords: دوتاستراید; Chemoprevention; Prostatic neoplasms; Testosterone 5α-reductase; Finasteride; Dutasteride; Micronutrients; Vitamins; Hydroxymethylglutaryl-CoA reductase inhibitors;
Phase II Study of Dutasteride for Recurrent Prostate Cancer During Androgen Deprivation Therapy
Keywords: دوتاستراید; dutasteride; prostatic neoplasms; clinical trial; phase II; prostate5αR, 5α-reductase; DHT, dihydrotestosterone; LHRH, luteinizing hormone-releasing hormone; NCI, National Cancer Institute; PSA, prostate specific antigen; RECIST, Response Evaluation Crite
Medical Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia
Keywords: دوتاستراید; Alfuzosin; Disease progression; Doxazosin; Dutasteride; Finasteride; Symptom reduction; Tamsulosin; Terazosin